US Stock MarketDetailed Quotes

IRWD Ironwood Pharmaceuticals

Watchlist

4.645
+0.115+2.54%

Trading Sep 13 10:16 ET

741.99MMarket Cap58.06P/E (TTM)

Ironwood Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-4.28%33.47M

-43.89%44.99M

-32.98%183.45M

-54.70%35.86M

-53.02%32.46M

-43.02%34.96M

25.02%80.17M

4.53%273.75M

22.65%79.16M

-7.96%69.09M

Net income from continuing operations

99.92%-860K

-109.10%-4.16M

-689.24%-1.03B

-103.57%-1.75M

-72.28%13.95M

-3,038.18%-1.09B

17.82%45.71M

-66.87%175.07M

18.11%48.87M

-9.90%50.32M

Operating gains losses

--37K

273.68%33K

89.44%-19K

--0

97.40%-19K

-114.16%-180K

-99.22%20K

92.77%-151K

Depreciation and amortization

87.41%506K

79.37%513K

14.29%1.6M

66.77%537K

39.67%507K

-25.00%270K

-19.44%286K

-6.67%1.4M

-4.17%322K

1.40%363K

Deferred tax

32.44%13.26M

-64.52%6.05M

10.49%72.64M

55.60%31.32M

-10.99%14.26M

-32.77%10.01M

15.94%17.05M

119.72%65.74M

941.33%20.13M

522.46%16.02M

Other non cash items

-99.95%550K

46.52%589K

58,557.62%1.1B

1,230.62%5.56M

46.50%586K

211,321.32%1.09B

-25.14%402K

-92.19%1.87M

-93.23%418K

-93.37%400K

Change In working capital

-23.78%11.41M

249.58%33.58M

299.96%11.28M

-500.23%-8.55M

3.54%-4.75M

1,105.88%14.97M

120.10%9.61M

-84.10%2.82M

-64.99%2.14M

-180.21%-4.92M

-Change in receivables

529.13%13.91M

299.41%57.11M

-88.44%924K

-588.47%-4.58M

61.25%-5.56M

-207.60%-3.24M

-22.22%14.3M

3.64%7.99M

107.55%937K

-4,405.71%-14.34M

-Change in prepaid assets

102.73%71K

28.95%-2.61M

30.89%4.22M

270.66%6.1M

54.36%4.39M

-97.34%-2.6M

-7,022.64%-3.67M

436.44%3.22M

0.80%1.65M

37.36%2.84M

-Change in payables and accrued expense

-139.93%-7.16M

-1,208.93%-21.98M

134.69%6.51M

-186.92%-6.95M

-169.96%-2.79M

751.49%17.93M

90.44%-1.68M

-265.18%-18.75M

-113.25%-2.42M

6.31%3.99M

-Change in other current assets

-1,227.59%-654K

8.51%408K

-24.46%1.12M

13.13%405K

-18.90%279K

-85.89%58K

2.45%376K

26.60%1.48M

110.59%358K

2.99%344K

-Change in other current liabilities

85.98%5.24M

131.54%646K

-116.76%-1.49M

-317.81%-3.52M

-147.46%-1.06M

49.34%2.82M

-91.09%279K

385.89%8.88M

202.54%1.62M

727.45%2.24M

Cash from discontinued investing activities

Operating cash flow

-4.28%33.47M

-43.89%44.99M

-33.00%183.43M

-54.74%35.83M

-53.02%32.46M

-43.02%34.96M

25.02%80.17M

4.53%273.76M

22.63%79.18M

-7.96%69.09M

Investing cash flow

Cash flow from continuing investing activities

99.99%-58K

-423.08%-68K

-754,545.59%-1.03B

-15,611.11%-4.19M

-34,180.30%-22.63M

-1,135,686.36%-999.49M

-44.44%-13K

48.68%-136K

121.09%27K

51.82%-66K

Net PPE purchase and sale

---58K

-423.08%-68K

-100.74%-273K

-881.48%-211K

25.76%-49K

--0

-44.44%-13K

48.68%-136K

121.09%27K

51.82%-66K

Net business purchase and sale

----

---1.03B

---3.98M

---22.58M

----

--0

Cash from discontinued investing activities

Investing cash flow

99.99%-58K

-423.08%-68K

-754,545.59%-1.03B

-15,611.11%-4.19M

-34,180.30%-22.63M

-1,135,686.36%-999.49M

-44.44%-13K

48.68%-136K

121.09%27K

51.82%-66K

Financing cash flow

Cash flow from continuing financing activities

-112.37%-49.37M

-490.73%-15.56M

216.67%277.16M

-1,914.11%-50.9M

-9,508.78%-74.99M

365.55%399.07M

104.38%3.98M

-5,120.95%-237.55M

115.10%2.81M

-87.07%797K

Net issuance payments of debt

-112.50%-50M

---25M

348.55%300M

---25M

---75M

--400M

--0

---120.7M

--0

Net common stock issuance

----

--0

----

-423.78%-126.39M

--0

Proceeds from stock option exercised by employees

-45.17%749K

152.73%10.06M

-33.36%6.36M

-64.43%998K

-98.49%12K

-68.34%1.37M

145.44%3.98M

-51.28%9.54M

-49.39%2.81M

-87.07%797K

Net other financing activities

---121K

---616K

---29.2M

---26.9M

--0

----

Cash from discontinued financing activities

Financing cash flow

-112.37%-49.37M

-490.73%-15.56M

216.67%277.16M

-1,914.11%-50.9M

-9,508.78%-74.99M

365.55%399.07M

104.38%3.98M

-5,120.95%-237.55M

115.10%2.81M

-87.07%797K

Net cash flow

Beginning cash position

-83.62%121.54M

-85.99%92.15M

5.80%657.94M

-80.65%111.46M

-65.10%176.62M

24.70%742.08M

5.80%657.94M

70.47%621.86M

-0.02%575.92M

2.26%506.1M

Current changes in cash

97.18%-15.97M

-65.10%29.36M

-1,668.25%-565.73M

-123.48%-19.26M

-193.31%-65.15M

-535.30%-565.46M

414.44%84.14M

-85.97%36.07M

78.87%82.02M

-13.90%69.82M

Effect of exchange rate changes

---51K

--24K

---53K

---50K

---3K

--0

----

End cash Position

-40.25%105.52M

-83.62%121.54M

-85.99%92.15M

-80.65%111.46M

-65.10%176.62M

24.70%742.08M

5.80%657.94M

-0.02%575.92M

Free cash flow

-4.45%33.41M

-43.96%44.92M

-33.06%183.15M

-55.03%35.62M

-53.05%32.41M

-42.94%34.96M

25.02%80.16M

4.59%273.63M

22.92%79.21M

-7.88%69.03M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-4.28%33.47M	-43.89%44.99M	-32.98%183.45M	-54.70%35.86M	-53.02%32.46M	-43.02%34.96M	25.02%80.17M	4.53%273.75M	22.65%79.16M	-7.96%69.09M
Net income from continuing operations	99.92%-860K	-109.10%-4.16M	-689.24%-1.03B	-103.57%-1.75M	-72.28%13.95M	-3,038.18%-1.09B	17.82%45.71M	-66.87%175.07M	18.11%48.87M	-9.90%50.32M
Operating gains losses	--37K	273.68%33K	89.44%-19K	--0	--0	--0	97.40%-19K	-114.16%-180K	-99.22%20K	92.77%-151K
Depreciation and amortization	87.41%506K	79.37%513K	14.29%1.6M	66.77%537K	39.67%507K	-25.00%270K	-19.44%286K	-6.67%1.4M	-4.17%322K	1.40%363K
Deferred tax	32.44%13.26M	-64.52%6.05M	10.49%72.64M	55.60%31.32M	-10.99%14.26M	-32.77%10.01M	15.94%17.05M	119.72%65.74M	941.33%20.13M	522.46%16.02M
Other non cash items	-99.95%550K	46.52%589K	58,557.62%1.1B	1,230.62%5.56M	46.50%586K	211,321.32%1.09B	-25.14%402K	-92.19%1.87M	-93.23%418K	-93.37%400K
Change In working capital	-23.78%11.41M	249.58%33.58M	299.96%11.28M	-500.23%-8.55M	3.54%-4.75M	1,105.88%14.97M	120.10%9.61M	-84.10%2.82M	-64.99%2.14M	-180.21%-4.92M
-Change in receivables	529.13%13.91M	299.41%57.11M	-88.44%924K	-588.47%-4.58M	61.25%-5.56M	-207.60%-3.24M	-22.22%14.3M	3.64%7.99M	107.55%937K	-4,405.71%-14.34M
-Change in prepaid assets	102.73%71K	28.95%-2.61M	30.89%4.22M	270.66%6.1M	54.36%4.39M	-97.34%-2.6M	-7,022.64%-3.67M	436.44%3.22M	0.80%1.65M	37.36%2.84M
-Change in payables and accrued expense	-139.93%-7.16M	-1,208.93%-21.98M	134.69%6.51M	-186.92%-6.95M	-169.96%-2.79M	751.49%17.93M	90.44%-1.68M	-265.18%-18.75M	-113.25%-2.42M	6.31%3.99M
-Change in other current assets	-1,227.59%-654K	8.51%408K	-24.46%1.12M	13.13%405K	-18.90%279K	-85.89%58K	2.45%376K	26.60%1.48M	110.59%358K	2.99%344K
-Change in other current liabilities	85.98%5.24M	131.54%646K	-116.76%-1.49M	-317.81%-3.52M	-147.46%-1.06M	49.34%2.82M	-91.09%279K	385.89%8.88M	202.54%1.62M	727.45%2.24M
Cash from discontinued investing activities
Operating cash flow	-4.28%33.47M	-43.89%44.99M	-33.00%183.43M	-54.74%35.83M	-53.02%32.46M	-43.02%34.96M	25.02%80.17M	4.53%273.76M	22.63%79.18M	-7.96%69.09M
Investing cash flow
Cash flow from continuing investing activities	99.99%-58K	-423.08%-68K	-754,545.59%-1.03B	-15,611.11%-4.19M	-34,180.30%-22.63M	-1,135,686.36%-999.49M	-44.44%-13K	48.68%-136K	121.09%27K	51.82%-66K
Net PPE purchase and sale	---58K	-423.08%-68K	-100.74%-273K	-881.48%-211K	25.76%-49K	--0	-44.44%-13K	48.68%-136K	121.09%27K	51.82%-66K
Net business purchase and sale	----	----	---1.03B	---3.98M	---22.58M	----	----	--0	--0	--0
Cash from discontinued investing activities
Investing cash flow	99.99%-58K	-423.08%-68K	-754,545.59%-1.03B	-15,611.11%-4.19M	-34,180.30%-22.63M	-1,135,686.36%-999.49M	-44.44%-13K	48.68%-136K	121.09%27K	51.82%-66K
Financing cash flow
Cash flow from continuing financing activities	-112.37%-49.37M	-490.73%-15.56M	216.67%277.16M	-1,914.11%-50.9M	-9,508.78%-74.99M	365.55%399.07M	104.38%3.98M	-5,120.95%-237.55M	115.10%2.81M	-87.07%797K
Net issuance payments of debt	-112.50%-50M	---25M	348.55%300M	---25M	---75M	--400M	--0	---120.7M	--0	--0
Net common stock issuance	----	----	--0	--0	----	----	----	-423.78%-126.39M	--0	--0
Proceeds from stock option exercised by employees	-45.17%749K	152.73%10.06M	-33.36%6.36M	-64.43%998K	-98.49%12K	-68.34%1.37M	145.44%3.98M	-51.28%9.54M	-49.39%2.81M	-87.07%797K
Net other financing activities	---121K	---616K	---29.2M	---26.9M	--0	----	----	----	----	----
Cash from discontinued financing activities
Financing cash flow	-112.37%-49.37M	-490.73%-15.56M	216.67%277.16M	-1,914.11%-50.9M	-9,508.78%-74.99M	365.55%399.07M	104.38%3.98M	-5,120.95%-237.55M	115.10%2.81M	-87.07%797K
Net cash flow
Beginning cash position	-83.62%121.54M	-85.99%92.15M	5.80%657.94M	-80.65%111.46M	-65.10%176.62M	24.70%742.08M	5.80%657.94M	70.47%621.86M	-0.02%575.92M	2.26%506.1M
Current changes in cash	97.18%-15.97M	-65.10%29.36M	-1,668.25%-565.73M	-123.48%-19.26M	-193.31%-65.15M	-535.30%-565.46M	414.44%84.14M	-85.97%36.07M	78.87%82.02M	-13.90%69.82M
Effect of exchange rate changes	---51K	--24K	---53K	---50K	---3K	--0	--0	--0	--0	----
End cash Position	-40.25%105.52M	-83.62%121.54M	-85.99%92.15M	-85.99%92.15M	-80.65%111.46M	-65.10%176.62M	24.70%742.08M	5.80%657.94M	5.80%657.94M	-0.02%575.92M
Free cash flow	-4.45%33.41M	-43.96%44.92M	-33.06%183.15M	-55.03%35.62M	-53.05%32.41M	-42.94%34.96M	25.02%80.16M	4.59%273.63M	22.92%79.21M	-7.88%69.03M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data